08/09/2017 Reuters
MEXICO CITY (Reuters) – Pharmaceutical companies including GlaxoSmithKline, Pfizer and Sanofi-Aventis face no competition for certain drugs in Mexico from generics that are readily available elsewhere, a senior Mexican antitrust official said on Wednesday.
The companies have done nothing illegal, Juan Manuel Espino, Cofece’s director of economic studies, said at a presentation of the body’s probe into the Mexican drugs market that found regulatory failings contributed to a lack of competition.
Mexico Institute 